Low-density lipoprotein cholesterol and risk of coronary heart disease among Japanese men and women: The Circulatory Risk in Communities Study (CIRCS)

Preventive Medicine

Volumn 52, Issue 5, 2011, Pages 381-386

  Imano, Hironori ^a,b   Noda, Hiroyuki ^a,b,c   Kitamura, Akihiko ^b   Sato, Shinichi ^d   Kiyama, Masahiko ^b   Sankai, Tomoko ^e   Ohira, Tetsuya ^a,b   Nakamura, Masakazu ^b   Yamagishi, Kazumasa ^e   Ikeda, Ai ^a,f   Shimamoto, Takashi ^b   Iso, Hiroyasu ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^c OSAKA UNIVERSITY HOSPITAL   (Japan)

^d CHIBA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^e UNIVERSITY OF TSUKUBA   (Japan)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cohort study; Coronary heart disease; Incidence; Low density lipoprotein cholesterol; Myocardial infarction; Population based study

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BLOOD SAMPLING; FEMALE; HEALTH SURVEY; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; JAPANESE; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; SUDDEN DEATH;

ADULT; AGED; CHOLESTEROL, LDL; COHORT STUDIES; CORONARY DISEASE; FEMALE; HEALTH SURVEYS; HUMANS; JAPAN; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS;

EID: 79954596620     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2011.02.019     Document Type: Article

References (19)

1. Chien K.L., Hsu H.C., Su T.C., et al. Apolipoprotein B and non-high density lipoprotein cholesterol and the risk of coronary heart disease in Chinese. J. Lipid Res. 2007, 48:2499-2505.
2. Durrleman S., Simon R. Flexible regression models with cubic splines. Stat. Med. 1989, 8:551-561.
3. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972, 18:499-502.
4. Imamura T., Doi Y., Arima H., et al. LDL cholesterol and the development of stroke subtypes and coronary heart disease in a general Japanese population: the Hisayama study. Stroke 2009, 40:382-388.
5. Imano H., Kitamura A., Sato S., et al. Trends for blood pressure and its contribution to stroke incidence in the middle-aged Japanese population: the Circulatory Risk in Communities Study (CIRCS). Stroke 2009, 40:1571-1577.
6. International guidelines for ethical review of epidemiological studies Law Med. Health Care 1991, 19:247-258.
7. Iso H., Shimamoto T., Kitamura A., Iida M., Komachi Y. Trends of cardiovascular risk factors and diseases in Japan: implications for primordial prevention. Prev. Med. 1999, 29:S102-S105.
8. Iso H., Naito Y., Sato S., et al. Serum triglycerides and risk of coronary heart disease among Japanese men and women. Am. J. Epidemiol. 2001, 153:490-499.
9. Law M.R., Wald N.J., Rudnicka A.R. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 2003, 326:1423.
10. Liu J., Sempos C.T., Donahue R.P., et al. Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease. Am. J. Cardiol. 2006, 98:1363-1368.
11. Nakamura M., Sato S., Shimamoto T. Improvement in Japanese clinical laboratory measurements of total cholesterol and HDL-cholesterol by the US Cholesterol Reference Method Laboratory Network. J. Atheroscler. Thromb. 2003, 10:145-153.
12. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143-3421.
13. Ng'andu N.H. An empirical comparison of statistical tests for assessing the proportional hazards assumption of Cox's model. Stat. Med. 1997, 16:611-626.
14. O'Keefe J.H., Cordain L., Harris W.H., et al. Optimal low-density lipoprotein is 50 to 70mg/dL: lower is better and physiologically normal. J. Am. Coll. Cardiol. 2004, 43:2142-2146.
15. Sacks F.M., Tonkin A.M., Shepherd J., et al. Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling Project. Circulation 2000, 102:1893-1900.
16. Shimamoto T., Komachi Y., Inada H., et al. Trends for coronary heart disease and stroke and their risk factors in Japan. Circulation 1989, 79:503-515.
17. Tremblay A.J., Morrissette H., Gagne J.M., et al. Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population. Clin. Biochem. 2004, 37:785-790.
18. Verschuren W.M., Jacobs D.R., Bloemberg B.P., et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. JAMA 1995, 274:131-136.
19. WHO Expert Committee Arterial hypertension and ischemic heart disease, preventive aspect. WHO technical report series no.231 1962, World Health Organization, Geneva.